聚羟乙谷氨酰胺-5-氟尿嘧啶-1-乙酸的合成、表征与缓释性

聚羟乙谷氨酰胺-5-氟尿嘧啶-1-乙酸的合成、表征与缓释性;高分子前药     

pH敏感的聚(L-谷氨酸)-交联聚丙烯酸水凝胶的合成与性能研究

通过在聚L-谷氨酸侧链部分接枝甲基丙烯酸2-羟乙酯得到含有双键的聚(L-谷氨酸),将其与丙烯酸共聚得到由聚(L-谷氨酸)侧链接枝并交联聚丙烯酸的pH敏感水凝胶.研究水凝胶在不同pH的缓冲溶液中的溶胀性、溶胀动力学,并通过SEM观察水凝胶的微观结构.结果表明,水凝胶在低pH环境下的溶胀率明显低于高pH环境中的溶胀率,不同...     

紫外光固化聚二甲基硅氧烷脲撑氨基甲酸甲基丙烯酸酯的研究——Ⅱ亲水疏水共聚网络体系

本文以α、ω-二氨丙基封端的聚二甲基硅氧烷、甲苯二异氰酸酯、甲基两烯酸羟乙酯为原料,合成了甲基丙烯酸酯封端的聚二甲基硅氧烷聚氨酯。并以此作为反应性低聚物,以甲基丙烯酸羟乙酯为亲水性反应稀释剂,通过紫外光固化,合成了一系列聚硅氧烷含量不同的共聚网络。应用红外光谱、凝胶含量测定、热分析、动态力学性能、吸水性实验等方法,对它们的固化程度、亲水疏水性能进行了研究。结果表明:体系中存在着两相结构,增加稀释剂的含量,材料的吸水性增加。通过调节疏水性的聚二甲基硅氧烷和亲水性的甲基丙烯酸羟乙酯的含量可改变体系的亲水疏水平衡。     

几种螯合剂解镍致小鼠急性肾毒性作用比较

为寻找镍(Ni)新型解毒剂，小鼠腹腔注射氯化镍溶液(5 mg Ni/kg)，观察二乙氨基二硫代甲酸钠(DDTC)，二羟乙氨基二硫代甲酸钠(DHED)，N-苯甲基-D-葡糖氨基二硫代甲酸钠(BGD)，meso-2，3-二巯基丁二酸钠(DMSA)及环己烷二胺四乙酸钠(CDTA)等螯合剂对镍致小鼠肾脏毒性的解毒作用。镍染毒引起小鼠肾脏脂质过氧化(LPO)和钙、铁及锌浓度增加，血清肌酐及血液尿素氮(BUN)升高。镍染毒30分钟和24小时后进行各螯合剂治疗(剂量均为400 μmol/kg     

几种螯合剂解镍致小鼠胰脏毒作用比较

小鼠腹腔注射氯化镍溶液(5 mg Ni/kg)染毒，观察了N-苯甲基-D-葡糖氨基二硫代甲酸钠(BGD)、二乙氨基二硫代甲酸钠(DDTC)、二羟乙氨基二硫代甲酸钠(DHED)及meso-2，3-二巯基丁二酸钠(DMSA)等螯合剂对镍致小鼠胰脏毒性的解毒作用。镍染毒后引起小鼠胰脏胰蛋白酶活性升高和羧肽酶A活性降低以及组织中镍、钙、锌浓度增加；镍染毒30 min和24 h后进行各螯合剂治疗(剂量均为400 μmol/kg)，BGD、DDTC和DMSA可明显抑制上述变化，其中BGD解镍毒效果最好、自身毒性最小、对镍致小鼠胰脏毒性有更好的解毒作用。     

三元无规接枝共聚物的合成及其自组装性能的研究

通过甲基丙烯酸羟乙酯(HEMA)引发ε-己内酯(ε-CL)开环聚合得到带有双键的大分子预聚体甲基丙烯酸羟乙酯-聚己内酯(HEMA-PCL), 该预聚体与N-异丙基丙烯酰胺(NIPAAm)及丙烯酸(AAc)自由基聚合得到一系列含有不同比例组分的三元无规接枝共聚物. 研究了该聚合物的自组装性能. 通过1H NMR, FTIR, 凝胶渗透色谱(GPC)对聚合物进行结构和分子量的表征. 通过TEM, DLS与表面张力等方法表征其纳米粒子情况.     

甲基丙烯酸磺酸基己酯钠盐的共聚合、聚合及其均聚物的抗凝血性能

研究了甲基丙烯酸6-磺酸基己酯钠盐与甲基丙烯酸甲酯、甲基丙烯酸β-羟乙酯及甲基丙烯酸正己酯的共聚合,并测定了它在水及二甲亚砜中的聚合速度关系式。聚甲基丙烯酸6-磺酸基己酯钠盐的抗凝血性能在一定分子量范围内相差不多。     

聚酯酸酐的合成及其药物释放性能研究

将对羟乙氧基苯甲酸分别与已二酰氯、癸二酰氯和对苯二甲酰氯反应,制备了含酯键的二羧酸.经熔融缩聚,合成了主链含酯键的新型聚酯酸酐.通过¹H NMR、IR及元素分析对单体及聚酯酸酐的结构进行了表征.研究了聚酯酸酐的体外降解和药物释放性能,其降解速率和释药速率次序为:聚4,4'-(已二酰氧二乙氧基)双对苯二甲酸＞聚4,4'-(癸二酰氧二乙氧基)双对苯二甲酸＞聚4,4'-(对苯二甲酰氧二乙氧基)双对苯二甲酸.     

新型可用于荧光标记的α-氰基丙烯酸酯单体的合成及在小鼠活体成像中的应用

设计合成了新型含有荧光基团的α-氰基丙烯酸酯单体,并与其它α-氰基丙烯酸酯单体共聚,得到产生荧光的聚氰基丙烯酸酯材料.将其包埋在小鼠背部肌肉层,可获得良好的荧光成像效果.通过对荧光强度的监测,初步研究了聚氰基丙烯酸酯材料中的侧链酯基在小鼠体内的降解情况.单体合成是以蒽合氰基丙烯酸和4,4'-二甲氧基三苯基-氨基己醇为原料,得到蒽合氰基丙烯酸(4,4'-二甲氧基三苯基-氨基己醇)酯,脱保护后再将异硫氰酸荧光素以化学键合的方式标记在末端氨基上,脱蒽还原烯双键后,得到可用于荧光标记的α-氰基丙烯酸(异硫氰酸荧光素-氨基己醇)酯单体.反应中间体及单体结构采用核磁共振氢谱和质谱进行表征.该单体及其高聚物均可在激发光(488 nm)和发射光(525 nm)条件下观察到明显荧光.     

一种萘酰亚胺衍生物的合成及其体外抗癌活性测定

合成了萘酰亚胺衍生物2-[2-(二甲基氨基)乙基]-6-2-(2-羟乙胺基)乙胺基-1H-苯并异喹啉-1,3(2H)-二酮;利用元素分析、核磁共振谱及质谱分析了其组成和结构;利用MTT法测定了其对人肝癌细胞(HepG2)、人乳腺癌细胞(MDA-MB-231)及人结肠癌细胞(HCT-116)的体外活性.结果表明,标题化合物的体外抗肿瘤活性优于对照品氨萘非特.     

锌对酒精性肝病小鼠的作用研究

为探究膳食补充锌是否改善肝再生,选用12周大的雄性C57BL/6小鼠40只,按随机数字表法分为4组:正常对照组、酒精中毒组、正常补锌组及酒精中毒补锌组,予不同的饮食喂养6个月后,通过增殖细胞核抗原(PCNA)阳性标记的肝细胞数目评价了肝细胞再生状况,并检测了超氧化物歧化酶(SOD)及丙二醛(MDA)含量评估肝损伤的氧化...     

Protective effects of baicalin and quercetin on an iron-overloaded mouse: comparison of liver, kidney and heart tissues

Excessive accumulation of iron in the body can lead to organ injury. Some flavonoids which possess high affinity to iron can be used as iron chelators for curing iron overload diseases such as haemochromatosis. In this article, the effects of baicalin and quercetin on different mouse tissues (liver, kidney and heart) afflicted with iron overload-induced injury were studied. It was found that after administration of 500 mg kg?1 iron dextran for 45 days, the degree of oxidative injury in the three organs was different. When iron dextran-induced iron-overloaded mice were fed a diet containing baicalin or quercetin (1% w/w), both flavonoids showed significant effects in suppressing iron overload-induced injury. The efficiencies of both flavonoids on different tissues varied. Both flavonoids caused a significant decrease of iron content in liver and kidney tissues but not in the heart, whereas the flavonoids were more efficient in inhibiting the increase of carbonyl content and the thiobarbituric acid reactive substance levels in heart tissues. The results indicate that the protective effects of baicalin and quercetin on different tissues of iron-overloaded mice are different.     

The Ameliorative Effects of Fucoidan in Thioacetaide-Induced Liver Injury in Mice

Liver disorders have been recognized as one major health concern. Fucoidan, a sulfated polysaccharide extracted from the brown seaweed Fucus serratus, has previously been reported as an anti-inflammatory and antioxidant. However, the discovery and validation of its hepatoprotective properties and elucidation of its mechanisms of action are still unknown. The objective of the current study was to investigate the effect and possible modes of action of a treatment of fucoidan against thioacetamide (TAA)-induced liver injury in male C57BL/6 mice by serum biochemical and histological analyses. The mouse model for liver damage was developed by the administration of TAA thrice a week for six weeks. The mice with TAA-induced liver injury were orally administered fucoidan once a day for 42 days. The treated mice showed significantly higher body weights; food intakes; hepatic antioxidative enzymes (catalase, glutathione peroxidase (GPx), and superoxide dismutase (SOD)); and a lower serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and C-reactive protein (CRP) levels. Additionally, a reduced hepatic IL-6 level and a decreased expression of inflammatory-related genes, such as cyclooxygenase-2 (COX-2), and inducible nitric oxide synthase (iNOS) mRNA was observed. These results demonstrated that fucoidan had a hepatoprotective effect on liver injury through the suppression of the inflammatory responses and acting as an antioxidant. In addition, here, we validated the use of fucoidan against liver disorders with supporting molecular data.     

Metabolically stable isotope labeling prior to electrophoretic protein separation reveals differences in fractional synthesis rates between mitochondrial aldehyde dehydrogenase isoforms

Living mice were subjected to whole body labeling by intravenous infusion of [(13)C]glucose as the sole carbon source. After 10 h infusion the mice were sacrificed, and liver proteins were separated by two-dimensional polyacrylamide gel electrophoresis. Five spots were found to contain mitochondrial aldehyde dehydrogenase (ALDH2) by matrix assisted time of flight mass spectrometry protein identification. By measuring the isotopologue mass distributions of peptide ions, and modeling the (13)C content of the precursor amino acid pool, the fractional synthesis rate of ALDH2 molecules synthesized during the labeling period was determined. One of the five spots was observed to have a five-fold higher fraction of (13)C-containing newly synthesized ALDH2 than the spot with the highest ALDH2 content, and contained more than 60% of newly synthesized ALDH2 although it accounted for less than 20% of the total ALDH2 detected. The total range in the fraction of (13)C-containing proteins between different ALDH2 spots approached 50-fold. The ability to quantitatively characterize different protein isoforms of biological origin for ALDH2 and other proteins from living animals provides new avenues for the exploration of protein function.     

In Vitro and In Vivo Digestibility of Soybean,Fish, and Microalgal Oils,and Their Influences on Fatty Acid Distribution in Tissue Lipid of Mice

The digestion rates of microalgal (docosahexaenoic acid, DHA, 56.8%; palmitic acid, 22.4%), fish (DHA, 10.8%; eicosapentaenoic acid, EPA, 16.2%), and soybean oils (oleic, 21.7%; linoleic acid, 54.6%) were compared by coupling the in vitro multi-step and in vivo apparent digestion models using mice. The in vitro digestion rate estimated based on the released free fatty acids content was remarkably higher in soybean and fish oils than in microalgal oil in 30 min; however, microalgal and fish oils had similar digestion rates at longer digestion. The in vivo digestibility of microalgal oil (91.49%) was lower than those of soybean (96.50%) and fish oils (96.99%). Among the constituent fatty acids of the diet oils, docosapentaenoic acid (DPA) exhibited the highest digestibility, followed by EPA, DHA, palmitoleic, oleic, palmitic, and stearic acid, demonstrating increased digestibility with reduced chain length and increased unsaturation degree of fatty acid. The diet oils affected the deposition of fatty acids in mouse tissues, and DHA concentrations were high in epididymal fat, liver, and brain of mice fed microalgal oil. In the present study, microalgal oil showed lower in vitro and in vivo digestibility, despite adequate DHA incorporation into major mouse organs, such as the brain and liver.     

Anti-diabetic Effects of Polysaccharides from Ethanol-insoluble Residue of Schisandra chinensis(Turcz.) Baill on Alloxan-induced Diabetic Mice

The ethanol-insoluble residue of Schisandra generated during lignans industrial production is usually treated as solid waste. However, there is active polysaccharide which could be used in it. In this work, the water-soluble polysaccharides from the ethanol-insoluble residue of Schisandra(ESCP) were obtained and their anti-diabetic effect was evaluated. The results indicate that ESCP could significantly reduce the blood glucose level in alloxan-induced diabetic mice. Moreover, the ESCP could significantly improve the lipid metabolism and increase the content of liver glycogen in alloxan-induced diabetic mice. The results indicate that ESCP could be developed into a potential natural hypoglycemic agent.     

菀葆牌硒蜜康对酒精性肝损伤保护作用的实验研究

为研究菀葆牌硒蜜康对小鼠酒精性肝损伤的保护作用,将动物随机分成溶剂对照组、溶剂模型组、蜂蜜对照组、蜂蜜模型组及低、中、高3个样品剂量组,共7组,每组10只,3个样品剂量组每天给予硒蜜康1667、3333、6667mg／（kg·d）,连续给予小鼠灌胃30d后,模型对照组和样品剂量组最后一次给予受试物后20min,按体质量计一次灌胃给予50％乙醇10mL／kg,对照组给双蒸水,禁食12h后处死,取动物肝脏,测定肝匀浆液MDA、GSH、TG含量;肝脏冰冻切片,进行病理组织学检查。结果表明,与蜂蜜模型组比较,中、低剂量组的GSH含量升高,各剂量组的TG含量降低,各剂量组冰冻病理学组织切片观察到脂肪变性评分低于模型对照组,差异均有显著性。可见菀葆牌硒蜜康对酒精性肝损伤具有辅助保护作用。     

亲水相互作用色谱-四极杆/静电场轨道阱高分辨质谱法测定肝组织中羟脯氨酸

采用亲水相互作用色谱-四极杆/静电场轨道阱高分辨质谱系统,建立了肝组织中胶原蛋白水解物羟脯氨酸(Hyp)的快速定量检测方法。将正常及四氯化碳肝纤维化模型小鼠的肝组织样品酸水解,经过滤、稀释后,采用Hypersil GOLD HILIC色谱柱(100 mm×2.1 mm,3μm)分离,以水-乙腈(28∶72,v/v)为流动相进行等度洗脱,最后用配有电喷雾离子源的四极杆/静电场轨道阱高分辨质谱在正离子模式下进行检测。结果表明,Hyp在0.78~100.00μg/L范围内呈良好的线性关系,相关系数(R2)为0.998 3,方法的定量限为0.78μg/L,样品加标回收率为97.4%~100.9%,相对标准偏差为1.4%~2.0%(n=6)。此外,该方法与传统的氯胺T法进行比较,发现两种方法的检测结果相关性良好,Pearson相关系数为0.927;较氯胺T法,该法具有操作简便、准确度高的优点。该方法可用于肝组织中Hyp的快速定量分析。     

Pharmacokinetic study of allixin, a phytoalexin produced by garlic

The pharmacokinetic behavior of allixin (3-hydroxy-5-methoxy-6-methyl-2-penthyl-4H-pyran-4-one) was investigated in an experimental animal, mice. Allixin was administered using an inclusion compound because the solubility of allixin in aqueous solution is very low. The allixin content in serum and in the organs of administered animals was analyzed by liquid chromatography (LC)-MS. Most of the administered allixin disappeared within 2 h, and the bioavailability of allixin was estimated to be 31% by obtained area under the blood concentration-time curve (AUC). The metabolites of allixin were studied using the metabolic enzyme fraction of liver and liver homogenate. Several new peaks corresponding to allixin metabolites were observed in the HPLC chromatoprofile. The chemical structure of the metabolites was investigated using LC-MS and NMR. Three of them were identified as allixin metabolites having a hydroxylated pentyl group.     

Studies on chemical protectors against radiation. XXXV. Effects of radioprotective Chinese traditional medicines on radiation-induced lipid peroxidation in vivo and in vitro.

The fluctuation of lipid peroxidation (LP) in 9 tissues was investigated in mice for 7 d after whole-body X-irradiation with a lethal dose of bone marrow death. LP increased significantly in bone marrow, thymus, spleen and liver following irradiation, and slightly in brain and testis, but not in blood plasma, submaxillary gland or kidney. The effects of 7 radioprotective Chinese traditional medicines (CTMs) and cysteamine (MEA) on the radiation-induced LP in 4 tissues were studied by i.p. injection before or after irradiation and their LP content in tissues was measured 2 d after irradiation. Most CTMs showed significant inhibition of radiation-induced LP in bone marrow and liver, especially when injected prior to irradiation. Some CTMs also showed such inhibition in spleen. MEA only inhibited the increase of LP in liver when injected before irradiation, but enhanced the increase of LP in spleen. None of these radioprotectors including MEA was recognized to inhibit radiation-induced LP in thymus. The in vitro experiments were carried out using mouse liver microsomal suspensions (MS). The MS were prepared from normal (non-irradiated) mice. Each of the 8 radioprotectors was added to MS before or after irradiation and then post-irradiation-incubated at 37 degrees C. All markedly inhibited radiation-induced LP if added before irradiation, but were slightly less effective if added after.